tiprankstipranks
Trending News
More News >
Leonardo DRS (DRS)
NASDAQ:DRS

Leonardo Drs (DRS) AI Stock Analysis

Compare
885 Followers

Top Page

DR

Leonardo Drs

(NASDAQ:DRS)

71Outperform
Leonardo DRS shows strong financial performance and positive earnings sentiment, indicating a solid foundation for growth. However, high valuation metrics and technical indicators suggesting overbought conditions introduce caution. While the company is well-aligned with defense priorities, challenges such as supply chain issues and margin pressures need to be managed.
Positive Factors
Defense Tech Modernization
Renewed emphasis on shipbuilding, coupled with continued strong defense tech modernization spend globally, is incrementally positive for DRS.
Financial Performance
DRS reported adjusted EPS above consensus and their own estimates, driven by stronger-than-expected operating performance.
Shareholder Initiatives
Management's change in stance to a more shareholder friendly capital deployment approach includes the company's first dividend payment and a share buyback program.
Negative Factors
Market Challenges
China's ban on germanium export poses a risk to the weapon sights business, although DRS has several years worth of supply on hand.
Operational Readiness
Trading volumes remain low and upside shipbuilding opportunities might not be realized until the South Carolina facility is operational.
Trading Multiples
The stock is trading at fair value with limited upside to current trading multiples.

Leonardo Drs (DRS) vs. S&P 500 (SPY)

Leonardo Drs Business Overview & Revenue Model

Company DescriptionLeonardo DRS (DRS) is a leading mid-tier defense contractor in the United States, specializing in advanced technology solutions for military and commercial customers. The company is part of Leonardo S.p.A., an Italian multinational aerospace, defense, and security company. Leonardo DRS operates in several sectors, including naval systems, communications and network technologies, electro-optical and infrared systems, and integrated mission systems. Its core products and services cater to the needs of U.S. military forces, homeland security agencies, and international allies, providing innovative solutions for surveillance, reconnaissance, and electronic warfare.
How the Company Makes MoneyLeonardo DRS generates revenue primarily through government contracts and defense procurement programs. A significant portion of its income comes from the U.S. Department of Defense, as it supplies various branches of the military with advanced technology and systems. The company also earns from international sales to allied nations, which rely on its expertise in areas like naval defense and electronic warfare systems. Additionally, Leonardo DRS engages in strategic partnerships and collaborations to enhance its product offerings and expand market reach, contributing to its revenue streams. The firm's ability to innovate and adapt its solutions to evolving defense needs plays a crucial role in maintaining a steady revenue flow.

Leonardo Drs Financial Statement Overview

Summary
Leonardo DRS presents strong financial performance with significant revenue growth and stable profitability. The company's low debt levels, strong balance sheet, and excellent cash flow generation enhance its financial robustness. Monitoring liquidity and capital allocation can further consolidate its position.
Income Statement
Leonardo DRS has shown strong revenue growth over recent years, with an increase from $2,778 million in 2020 to $3,345 million in TTM (Trailing-Twelve-Months). The gross profit margin has improved to 22.7%, reflecting efficient cost management. The EBIT margin is consistent at 9.3%, and the net profit margin is solid at 7.0%. These metrics indicate robust profitability and operational efficiency, making the income statement a strong point for the company.
Balance Sheet
78
The company's balance sheet reveals a stable financial position with a debt-to-equity ratio of 0.14, indicating low leverage. The equity ratio stands at 62.8%, highlighting a strong equity base. The return on equity is healthy at 9.1%, showing effective use of shareholder funds. Overall, the balance sheet is solid, though there is room for improvement in liquidity and asset utilization.
Cash Flow
Leonardo DRS demonstrates positive cash flow dynamics with a significant increase in free cash flow to $291 million in TTM. The operating cash flow to net income ratio is 1.70, indicating strong cash generation relative to earnings. The free cash flow growth rate is impressive, highlighting the company's ability to generate surplus cash even after capital expenditures. These factors contribute to a strong cash flow position.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
3.23B2.83B2.69B2.88B2.78B
Gross Profit
736.00M648.00M575.00M547.00M494.00M
EBIT
293.00M231.00M561.00M236.00M181.00M
EBITDA
376.00M313.00M624.00M293.00M229.00M
Net Income Common Stockholders
213.00M168.00M405.00M154.00M85.00M
Balance SheetCash, Cash Equivalents and Short-Term Investments
598.00M467.00M306.00M240.00M61.00M
Total Assets
4.18B3.92B3.68B3.07B2.96B
Total Debt
458.00M497.00M394.00M490.00M530.00M
Net Debt
-140.00M30.00M88.00M250.00M469.00M
Total Liabilities
1.63B1.60B1.55B1.48B1.53B
Stockholders Equity
2.56B2.33B2.13B1.59B1.43B
Cash FlowFree Cash Flow
186.00M145.00M-32.00M118.00M69.00M
Operating Cash Flow
271.00M205.00M33.00M178.00M125.00M
Investing Cash Flow
-84.00M-59.00M436.00M39.00M-70.00M
Financing Cash Flow
-56.00M15.00M-403.00M-38.00M-80.00M

Leonardo Drs Technical Analysis

Technical Analysis Sentiment
Positive
Last Price42.00
Price Trends
50DMA
33.33
Positive
100DMA
33.57
Positive
200DMA
31.62
Positive
Market Momentum
MACD
1.70
Negative
RSI
74.60
Negative
STOCH
89.40
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DRS, the sentiment is Positive. The current price of 42 is above the 20-day moving average (MA) of 35.62, above the 50-day MA of 33.33, and above the 200-day MA of 31.62, indicating a bullish trend. The MACD of 1.70 indicates Negative momentum. The RSI at 74.60 is Negative, neither overbought nor oversold. The STOCH value of 89.40 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DRS.

Leonardo Drs Risk Analysis

Leonardo Drs disclosed 55 risk factors in its most recent earnings report. Leonardo Drs reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Leonardo Drs Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$10.29B36.6928.00%0.86%8.31%14.74%
DRDRS
71
Outperform
$11.17B52.789.50%0.21%13.58%25.96%
ERERJ
71
Outperform
$8.59B24.3312.07%22.75%117.20%
HIHII
71
Outperform
$9.03B16.5812.27%2.30%-1.04%-21.80%
64
Neutral
$4.27B11.815.31%249.66%4.08%-8.61%
63
Neutral
$9.33B874.29
14.77%
55
Neutral
$10.61B-40.59%78.34%-1.13%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DRS
Leonardo Drs
42.00
20.51
95.44%
ERJ
Embraer SA
46.72
19.64
72.53%
HII
Huntington Ingalls
230.02
-10.63
-4.42%
BWXT
BWX Technologies
112.61
14.67
14.98%
RKLB
Rocket Lab USA
22.99
18.93
466.26%
SARO
StandardAero, Inc.
27.89
-5.08
-15.41%

Leonardo Drs Earnings Call Summary

Earnings Call Date:Oct 30, 2025
(Q1-2025)
|
% Change Since: 13.64%|
Next Earnings Date:Mar 31, 2026
Earnings Call Sentiment Positive
Leonardo DRS reported strong Q1 performance with significant bookings, backlog growth, and strategic alignment with defense priorities. However, challenges related to supply chain disruptions and margin pressures in the ASC segment were noted. The overall business outlook remains positive, supported by robust demand and operational improvements.
Q1-2025 Updates
Positive Updates
Strong Bookings and Backlog
Leonardo DRS secured nearly $1 billion in bookings in Q1, translating to a 1.2 book-to-bill ratio. The company achieved its 13th consecutive quarter with a book-to-bill above 1, increasing the backlog to $8.6 billion.
Remarkable Organic Growth
The company experienced organic growth of 16% in Q1, with profit expansion and improved cash flow, driven by material receipts pulled into the quarter.
Successful Capital Return Initiatives
Leonardo DRS commenced the execution of capital return initiatives with the payment of its first dividend and initial stock repurchases.
Advanced Infrared Sensing Demand
High demand was noted for advanced infrared sensing, electric power and propulsion, and tactical radars, contributing to the company's growth.
Positive Adjusted EBITDA Growth
Adjusted EBITDA in Q1 was $82 million, representing a 17% growth from last year.
Defense Budget Alignment
The company is well-aligned with U.S. defense priorities, particularly in shipbuilding, force protection, and the nuclear triad.
Negative Updates
Supply Chain Challenges
Challenges arose with a sole source optics supplier unable to execute on purchase orders due to China's restrictions on rare earth minerals, impacting profitability.
ASC Margin Pressure
ASC segment margin declined by 130 basis points due to negative contract adjustments and increased germanium costs.
International Program Supplier Issue
A supplier issue on an international program led to increased costs as Leonardo DRS sought alternative germanium sources.
Potential Tariff Impacts
The potential implications of tariffs were discussed, although the company expects relative insulation due to its U.S.-centric operations.
Company Guidance
During the Leonardo DRS First Quarter Fiscal Year 2025 Earnings Conference Call, the company reported strong financial performance, surpassing expectations with a 16% organic growth in revenue and adjusted EBITDA growth of 17%, reaching $82 million. The company's book-to-bill ratio was 1.2, with nearly $1 billion in bookings that increased the backlog to a record $8.6 billion. Leonardo DRS maintained its full-year guidance, projecting revenue between $3.45 billion and $3.525 billion, with an adjusted EBITDA forecast of $435 million to $455 million and adjusted diluted EPS in the range of $1.02 to $1.08. The company highlighted its diversified portfolio, strong demand across its segments, and ongoing capital return initiatives, including dividends and stock repurchases. Despite a dynamic operating environment and challenges such as increased germanium costs, the company expressed confidence in its ability to achieve its 2025 outlook, supported by a robust defense budget and strategic alignment with national defense priorities.

Leonardo Drs Corporate Events

Financial Disclosures
Leonardo DRS Reports Strong Q1 2025 Financial Results
Positive
May 1, 2025

Leonardo DRS reported strong financial results for the first quarter of 2025, ending March 31, with a 16% increase in revenue to $799 million and a 72% rise in net earnings to $50 million compared to the previous year. The company also achieved a book-to-bill ratio of 1.2x with $1 billion in bookings and an $8.6 billion backlog, reflecting robust demand for its products and services. The improved profitability and reduced cash flow usage indicate a solid start to the year, positioning the company well for future growth and shareholder returns.

Spark’s Take on DRS Stock

According to Spark, TipRanks’ AI Analyst, DRS is a Outperform.

Leonardo DRS’s strong financial performance and positive earnings call sentiment are significant strengths, supported by robust revenue growth and strategic investments. Technical analysis shows a positive price trend, but high valuation and potential risks from policy changes and supply chain issues present notable challenges.

To see Spark’s full report on DRS stock, click here.

Stock BuybackDividendsFinancial Disclosures
Leonardo DRS Reports 14% Revenue Growth for 2024
Positive
Feb 20, 2025

Leonardo DRS announced its financial results for the fourth quarter and full year 2024, highlighting a 14% revenue growth for the year driven by key programs in advanced infrared sensing and tactical radars. The company also declared a dividend of $0.09 per share to be paid in March 2025 and authorized a $75 million stock repurchase program. These moves, alongside strong financial performance, signal the company’s stable financial health and commitment to shareholder value.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.